The Architectural Foundation of Modern Telehealth Solutions

To understand how telemedicine platforms expanding access to remote care function so effectively, one must look at the underlying technological architecture that supports them. These platforms are far more than simple video conferencing tools. They are comprehensive ecosystems designed to handle sensitive health data, facilitate real-time diagnostics, and manage complex scheduling workflows across multiple time zones. By integrating electronic health records with secure video interfaces, these systems provide clinicians with a holistic view of a patient’s history while they are engaged in a virtual session. This synergy ensures that the care provided is as informed and precise as any face-to-face encounter. Furthermore, the scalability of these platforms allows healthcare organizations to reach thousands of individuals simultaneously, leveraging cloud computing to ensure that service remains stable even during peak demand periods.

Breaking Down Geographical Barriers in Rural Communities

One of the most profound impacts of telemedicine platforms expanding access to remote care is visible in the revitalization of rural healthcare. In many isolated regions, the shortage of specialists is a chronic issue, often forcing patients to travel for hours to receive basic consultations or follow-up care. The introduction of virtual consultations has effectively eliminated this “distance tax” on health. Patients in remote townships can now connect with top-tier cardiologists, neurologists, or mental health professionals without leaving their local clinics or, in many cases, their own living rooms. This democratization of expertise is critical for early intervention, where the time saved in travel can be the difference between a manageable condition and a life-threatening crisis. By providing a direct link to urban medical centers, these platforms empower rural general practitioners with a support network of specialists, creating a collaborative environment that elevates the standard of care for the entire community.

The Role of Digital Triage in Optimizing Patient Flow

A key component of these systems is the implementation of digital triage, which serves as the first point of contact for many patients entering the virtual care stream. Digital triage utilizes sophisticated algorithms and clinician-supervised questionnaires to assess the severity of a patient’s symptoms before they ever speak to a human provider. This process is essential for telemedicine platforms expanding access to remote care because it ensures that limited medical resources are directed toward those with the highest acuity. Instead of clogging emergency rooms with non-urgent cases, patients can be routed to the appropriate level of care, whether that is a same-day virtual consultation, a prescription refill, or advice for home management. This efficiency not only reduces the burden on physical hospital infrastructure but also minimizes the risk of infectious disease transmission, a lesson that has become permanently etched into the consciousness of the modern medical establishment.

Enhancing Patient Engagement and Longitudinal Care Management

Beyond the immediate crisis or acute consultation, telemedicine platforms expanding access to remote care are proving to be indispensable tools for chronic disease management. Conditions like diabetes, hypertension, and chronic obstructive pulmonary disease require constant monitoring and frequent adjustments to treatment plans. Traditional models of care often see patients falling through the cracks between quarterly appointments. Digital health platforms fill these gaps by facilitating regular, low-friction touchpoints between the patient and their care team. Through integrated wearable devices and mobile health apps, data on vital signs can be transmitted in real-time, allowing clinicians to notice trends and intervene before a complication arises. This proactive approach fosters a stronger sense of partnership between patients and providers, as individuals become more engaged in tracking their own health metrics and understanding the impact of their lifestyle choices.

Overcoming the Challenges of Digital Literacy and Infrastructure

While the promise of telemedicine platforms expanding access to remote care is immense, the transition is not without its hurdles. The “digital divide” remains a significant concern, as those who could benefit most from remote services often lack the high-speed internet or the technical proficiency required to navigate complex software. To address this, forward-thinking developers are focusing on “low-bandwidth” versions of their platforms and designing user interfaces that are intuitive for elderly populations or those with limited tech experience. Moreover, public-private partnerships are increasingly targeting infrastructure improvements in “last-mile” areas, recognizing that broadband access is now a social determinant of health. As these barriers are systematically dismantled, the reach of virtual consultations will continue to expand, ensuring that the benefits of the digital health revolution are shared equitably across all demographic sectors.

The Future of Remote Diagnostics and Integrated Care

Looking forward, the capabilities of telemedicine platforms expanding access to remote care will only grow as they incorporate emerging technologies like artificial intelligence and augmented reality. We are moving toward a future where a virtual consultation might include a remote physical exam assisted by AI-powered diagnostic tools that a patient can use at home. Imagine a scenario where a platform guides a patient through the use of a digital stethoscope or a handheld ultrasound device, with the data interpreted instantly by an AI and verified by a remote physician. This level of integration would further close the gap between virtual and in-person care, making the platform a truly comprehensive medical hub. As these technologies mature, the distinction between “telemedicine” and “medicine” will likely vanish, as digital interaction becomes a standard, seamless part of every patient’s healthcare journey.

Economic Implications and Healthcare Sustainability

From an economic perspective, the shift toward telemedicine platforms expanding access to remote care offers a pathway to more sustainable healthcare spending. By reducing the overhead costs associated with maintaining large physical facilities and decreasing the frequency of unnecessary hospital admissions through better triage and monitoring, these platforms can significantly lower the per-patient cost of care. For insurance providers and national health systems, this represents an opportunity to reallocate funds toward preventative measures and the development of new treatments. For the patient, it means fewer lost wages from travel and time off work, as well as more affordable access to specialized services. In an era where healthcare costs are spiraling upward globally, the efficiency gains provided by digital health tools are not just a luxury but a necessity for the long-term viability of public health systems.

Ethical Considerations and Data Privacy in a Virtual World

As we lean more heavily on telemedicine platforms expanding access to remote care, the ethical implications of data privacy and security take center stage. The transition of medical interactions to the digital realm creates a vast trail of highly personal information that must be protected against breaches and misuse. This requires a robust regulatory framework and a commitment from platform developers to utilize end-to-end encryption and rigorous identity verification. Beyond security, there is the ethical question of maintaining the “human touch” in medicine. While virtual consultations are efficient, the empathetic connection between a doctor and patient is a cornerstone of healing. The most successful telemedicine platforms will be those that use technology to enhance, rather than replace, the human element, providing a space where patients feel heard, understood, and respected despite the digital medium.

Conclusion: A New Era of Inclusive Healthcare

The expansion of telemedicine platforms is fundamentally a story of human ingenuity meeting a critical social need. By leveraging the power of connectivity, we are finally beginning to solve the age-old problem of medical scarcity. Telemedicine platforms expanding access to remote care have proven that quality healthcare is not a fixed point in space but a service that can be delivered wherever a signal can reach. As we continue to refine these tools, improve our digital infrastructure, and integrate virtual care into the broader tapestry of the medical system, we move closer to a world where a person’s zip code no longer determines their life expectancy. The journey toward fully accessible, remote-first healthcare is well underway, and its success will be measured by the millions of lives improved through timely, expert care delivered right where it is needed most.

Traditional clinical trials have historically required patients to travel repeatedly to centralized research sites for study visits, laboratory assessments, and clinical evaluations—a substantial burden that excludes many potential participants from research participation. Elderly patients, individuals with mobility limitations, rural populations, and busy working professionals frequently cannot accommodate the time commitment and travel requirements of traditional site-centric trials. This structural limitation has resulted in clinical research populations that systematically underrepresent demographic and geographic diversity, generating evidence applicable primarily to privileged populations capable of participating in traditional trial models. Decentralized clinical trials fundamentally address this equity issue by eliminating geographical barriers and time burdens through remote participation options. The resulting expansion of potential participants enables dramatically faster recruitment, more representative study populations, and more generalizable evidence reflecting broader population characteristics.

The convergence of digital health technologies, regulatory evolution, and healthcare stakeholder alignment creates unprecedented opportunity for decentralized trial adoption. Remote work normalization accelerated by global pandemics demonstrated that sophisticated clinical activities including informed consent, vital sign monitoring, and laboratory sample collection can occur effectively outside traditional clinical facilities. Regulatory agencies increasingly embrace decentralized approaches, establishing frameworks for evaluating remote trial methodologies. Participants increasingly expect convenient research options accommodating their individual circumstances. Organizations embracing decentralized trial innovations will establish competitive advantages through faster recruitment, improved diversity, enhanced retention, and superior evidence generation while simultaneously advancing health equity by expanding research access.

Revolutionizing Clinical Research Through Remote Participation

The traditional clinical trial model has persisted for decades—patients travel to designated research sites for multiple study visits spanning months or years, undergoing standardized assessments according to fixed schedules regardless of individual circumstances. This site-centric approach introduced substantial barriers to participation, particularly for elderly individuals, rural populations, patients with mobility limitations, and busy working professionals. Consequently, clinical research populations systematically excluded substantial demographic segments, generating evidence applicable primarily to the specific populations capable of participating in traditional trial formats. Decentralized clinical trials represent a fundamental departure from this model, replacing site-centric research with remote, patient-centric approaches where participants engage with research activities from their homes and receive clinical support through telehealth and digital health technologies.

Decentralized clinical trials leverage sophisticated digital health technologies to enable comprehensive trial participation without requiring travel to centralized research sites. Telemedicine platforms replace traditional office visits for safety monitoring and clinical assessments. Wearable biosensors continuously monitor physiological parameters rather than relying on occasional laboratory measurements. Electronic platforms enable informed consent and ongoing engagement without requiring physical documentation. Mobile health applications facilitate patient-reported outcomes collection and medication adherence monitoring. By eliminating geographical constraints and reducing time burdens, these technological innovations fundamentally transform who can participate in clinical research. The resulting expansion of eligible participant populations enables substantially faster enrollment, more representative study cohorts, and accelerated identification of effective treatments.

Telehealth and Virtual Site Visits

Telemedicine represents a cornerstone technology enabling decentralized clinical trials, replacing traditional office visits with video-based clinical interactions between patients and research staff. Through telehealth platforms, patients participate in informed consent discussions, safety evaluations, treatment initiation discussions, and ongoing monitoring without traveling to physical research facilities. Healthcare providers conduct clinical assessments including vital sign measurement—facilitated by home-based blood pressure monitors and pulse oximeters—and engage in detailed clinical interviews exploring symptoms, tolerability, and treatment response. This virtual care model maintains clinical rigor while eliminating geographical constraints and travel burden.

The practical implementation of telehealth in decentralized clinical trials requires thoughtful attention to technology selection, user interface design, and clinical workflow integration. Platforms must be intuitive enough for elderly individuals and patients unfamiliar with technology while maintaining security and regulatory compliance standards. Clinical staff require training regarding conducting assessments through telehealth, as physical examination and patient observation differ substantially from traditional office-based encounters. Despite these implementation considerations, telehealth has demonstrated remarkable effectiveness in enabling clinical research participation. Patients report high satisfaction with virtual visit models, particularly when given choice between remote and in-person options. The flexibility of virtual visits enables scheduling that accommodates patient work schedules, reducing scheduling barriers that traditionally limited trial participation.

Wearable Devices and Continuous Monitoring

A fundamental advantage of decentralized trials over traditional research involves the capacity for continuous monitoring through wearable biosensors and home-based medical devices. Traditional trials conducted snapshot assessments during site visits—typically measuring vital signs and collecting brief clinical observations at infrequent intervals. In contrast, wearables enable continuous collection of heart rate, activity levels, sleep patterns, skin temperature, and other physiological parameters throughout trial duration. This continuous data stream provides substantially richer information regarding patient status and treatment response compared to episodic site-based measurements.

Machine learning algorithms analyze wearable data streams to identify subtle patterns indicative of treatment response, emerging safety issues, or disease progression. Algorithms can recognize anomalies suggesting increased infection risk, cardiac arrhythmias, or other safety concerns before patients experience obvious symptoms, enabling early intervention. By monitoring continuously, decentralized trials detect safety signals faster than traditional site-based trials dependent on patient symptom reporting and infrequent clinical assessments. This enhanced safety monitoring represents substantial clinical value—potentially preventing serious adverse events through early identification and appropriate clinical intervention.

Electronic Informed Consent and Digital Engagement

Traditional clinical trials required paper-based informed consent processes where patients reviewed lengthy consent documents and provided signatures at research sites. Electronic consent (eConsent) platforms transform this process by presenting informed consent information through interactive digital formats accessible from patients’ homes. Video presentations, animated explanations, and interactive quizzes ensure patients comprehend essential trial information before confirming consent. Digital platforms create permanently accessible records of consent discussions, reducing subsequent misunderstandings or disputes regarding what patients understood.

Beyond initial consent, digital engagement platforms maintain ongoing communication with trial participants throughout research duration. Study teams use electronic platforms to deliver educational materials regarding trial participation, medication administration, and symptom reporting. Patients access personalized dashboards displaying their trial data, progress toward endpoints, and relevant clinical milestones. This transparent, continuous engagement enhances patient understanding of trial purpose and personal participation importance, improving retention and adherence compared to traditional trials with minimal patient communication. Electronic engagement platforms further enable rapid dissemination of protocol modifications or emerging safety information, ensuring all trial participants receive timely information regarding trial conduct.

Patient-Reported Outcomes and Remote Monitoring

Decentralized trials extensively employ patient-reported outcomes (PRO) collection through electronic platforms rather than relying exclusively on clinician-assessed measurements. Patients report symptoms, functional status, quality of life, and treatment side effects through convenient digital interfaces accessible from their phones or home computers. This direct patient reporting captures information unavailable through traditional objective clinical assessments—patients’ subjective experiences with treatment, medication adherence challenges, and lifestyle impacts.

Mobile health applications facilitate daily or weekly PRO collection, enabling detection of subtle changes in patient status that might be missed through infrequent traditional assessments. For instance, in a depression trial, daily mood tracking through a mobile application would detect mood fluctuations and symptom patterns that patients cannot accurately recall during traditional site visits weeks apart. Machine learning algorithms process these frequent PRO measurements, identifying patterns predictive of treatment response or emerging safety concerns. The longitudinal nature of remote monitoring data provides substantially greater insight into treatment effects compared to episodic site-based assessments. Patients further appreciate the convenience of reporting from home and viewing their own data through personal dashboards, enhancing engagement and retention.

Home Nursing Visits and Sample Collection

While many trial activities can occur remotely through telehealth, certain procedures require in-person assessment and biological sample collection. Decentralized trials address this through home nursing visits—nurses travel to patients’ homes to conduct safety assessments, draw blood samples, or collect other biological specimens according to trial protocols. This approach maintains clinical rigor for procedures requiring direct observation and sample collection while eliminating requirement for patients to travel to centralized sites.

Home nursing services substantially improve trial accessibility for patients with mobility limitations, transportation barriers, or geographic distance from research sites. Elderly individuals with driving limitations, patients with severe disease affecting mobility, and rural residents living hours from research facilities can all participate comfortably when services come to them. Scheduling flexibility further enhances accessibility—home nurses coordinate appointments around patient availability rather than requiring patients to accommodate fixed site-based visit schedules. The increased accessibility generated by home nursing services dramatically expands the pool of potential trial participants, enabling enrollment of populations systematically excluded from traditional site-centric trials.

Expansion of Geographic Reach and Demographic Diversity

One of the most significant advantages of decentralized trials involves expansion of geographic reach beyond traditional research site locations. Traditional trials concentrate participants in urban areas with established research infrastructure, systematically excluding rural and underserved communities. Decentralized approaches eliminate this geographic limitation—patients anywhere with internet access can potentially participate through remote visit platforms. Rural patients with limited local healthcare infrastructure gain access to cutting-edge research participation opportunities previously unavailable in their communities.

This geographic expansion translates into substantial improvements in trial demographic diversity. Rural populations historically underrepresented in clinical research now have realistic participation options. Similarly, decentralized trials enable recruitment of patients in developing nations where clinical research infrastructure remains limited. The resulting more diverse trial populations generate evidence more representative of broader population characteristics. Regulatory agencies increasingly recognize health equity value of diverse trial populations, viewing demographic diversity as indicator of higher-quality evidence more applicable to diverse patient populations. Organizations conducting decentralized trials with substantial demographic diversity gain competitive advantages in regulatory interactions and market positioning.

Operational Efficiency and Cost Considerations

While decentralized trials require investments in digital health infrastructure, telemedicine platforms, and wearable device integration, the operational efficiency gains often offset these incremental technology costs. Traditional site-based trials require substantial ongoing expenses for site facilities, staff, regulatory compliance, and participant travel reimbursement. Decentralized trials reduce these physical infrastructure costs while utilizing distributed nursing networks and telehealth platforms. For trials enrolling geographically dispersed populations, decentralized approaches generate substantial cost savings compared to site-based models requiring expensive establishment of research facilities in multiple locations.

Faster recruitment enabled by expanded eligible participant populations represents additional cost benefit of decentralized trials. Reduced recruitment timeline translates directly into shortened overall trial duration, reducing ongoing operational expenses for data management, regulatory monitoring, and site management. Enhanced retention through convenience and accommodation of individual circumstances reduces wasteful expenses associated with participant dropout and replacement recruitment. Collectively, these operational efficiencies often result in decentralized trials generating evidence at comparable or lower cost compared to traditional site-based trials while simultaneously generating higher-quality evidence from more diverse, representative populations.

Data Quality and Real-World Evidence Generation

Decentralized trials generate rich, longitudinal data reflecting patient status in real-world settings rather than episodic measurements conducted in artificial research environments. Continuous wearable monitoring captures actual daily living conditions and treatment responses in patients’ authentic environments rather than constrained clinical settings. Patient-reported outcomes submitted frequently from home reflect genuine patient experiences rather than recollections of events weeks prior. Biological samples collected through home nursing services maintain scientific rigor while reflecting real-world treatment response in patients’ natural environments.

This real-world data generation transforms decentralized trials into practical mechanisms for generating real-world evidence—research conducted outside traditional controlled trial environments using pragmatic trial designs reflecting actual clinical practice. Real-world evidence increasingly influences clinical decision-making, regulatory approvals, and healthcare policy. By demonstrating treatment effectiveness in real-world conditions, decentralized trials provide evidence more relevant to clinical practice than traditional efficacy trials conducted under highly controlled conditions. Payers, regulators, and clinicians increasingly value real-world evidence demonstrating that treatments work effectively under practical conditions rather than only under idealized research circumstances.

Implementation Challenges and Future Opportunities

Successfully implementing decentralized trials requires careful attention to regulatory compliance, data security, and participant access to technology. Regulatory frameworks for remote trials continue evolving—organizations must remain current regarding regulatory requirements regarding telehealth use, electronic consent validity, and remote monitoring standards. Data security becomes critical when transmitting sensitive patient information through multiple digital platforms—organizations must invest in robust cybersecurity infrastructure protecting participant privacy.

Technology access remains an implementation consideration, as not all potential participants possess reliable internet access, smartphones, or familiarity with digital health platforms. Organizations conducting decentralized trials must provide technology support and device access to ensure that digital barriers do not recreate the inequities decentralized trials aim to address. By thoughtfully addressing these implementation challenges, organizations can leverage decentralized trial advantages while maintaining quality, compliance, and accessibility standards.

Transforming Clinical Research Accessibility

The trajectory of decentralized clinical trials demonstrates profound potential for democratizing research access and expanding health equity. As digital health technologies mature and regulatory frameworks evolve, decentralized approaches will become increasingly standard across pharmaceutical research. Patients will increasingly expect research opportunities accommodating their individual circumstances rather than requiring adaptation to rigid site-centric trial models. Organizations embracing decentralized trial innovations will establish substantial competitive advantages through faster recruitment, enhanced diversity, improved retention, and superior evidence generation. The future of clinical research will involve increasingly patient-centric models where research accommodates participants’ lives rather than requiring participants to accommodate research schedules and locations.

The fact is that technology in healthcare is no longer confined to clinics or hospitals. The growth of digital health platforms along with AI-driven diagnostics has gone on to pave the path for technology-focused careers related to healthcare. Professionals who go on to accept these advancements are going to be better positioned for the future. It is well to be noted that the healthcare sector is evolving at a brisk pace. Those who consistently upgrade their skills and specialize in novel areas are going to have the most apt career prospects in the years to come.

Major Digital Skills for Healthcare Professionals

Health professionals can enhance their career prospects by acquiring the following digital skills:

Electronic health record (EHR) management

Healthcare facilities make use of EHR systems so as to store as well as manage the data of patients. Professionals should be skilled when it comes to documentation, retrieving it, and also evaluating patient information in an efficient way. Understanding the compliance regulation along with data security like HIPAA for the ones working with US-based systems is also critical.

Telemedicine and remote patient tracking

In the telehealth era, healthcare professionals should be acquainted with virtual consultation platforms. Training when it comes to how to conduct remote evaluation, gauge numerous patient data coming from the wearable devices, and apply telemedicine as one of the complementary tools for conventional care will enhance the service delivery.

Data analytics and their AI application

Healthcare, undoubtedly, is going through a paradigm shift due to data-driven decision-making. There is a rapidly rising need for professionals who can evaluate trends from the patient data, predict healthcare outcomes, and at the same time use AI tools. The application of AI when it comes to treatment, planning, diagnostics, and also administrative automation is growing multifold, therefore making it worthy to understand such tools.

Digital health tools with mobile applications

It is worth noting that mobile health applications help patients to manage their condition and follow prescribed treatments. This happens to be the potential means by which healthcare professionals share such innovative technology with patients, such as embraced by health fitness trackers, reminders to take medication to patients, as well as symptom checkers.

Cybersecurity awareness

With patient information going online, the healthcare workers understand the possible risk that cybersecurity possesses. Training to recognize phishing scams, make use of strong passwords, and also make sure of compliance with data privacy law can aid in safeguarding from breaches while at the same time ensuring patient privacy.

Emerging role of medical tech and 3-D printing

Upgraded innovations, such as implants, prostheses, organ models, etc., make use of 3-D printing. Medical professionals consistently learn about these advancements in order to improve patient care along with medical research.

Automation and robotics and healthcare

Surgeries that are assisted by robotics and even AI have gone on to automate many activities within hospitals by making them more effective and bringing down the human error.

Social media and digital marketing influence on healthcare

Medical professionals must consider this within their marketing strategy in order to make their name prominent when using digital channels in order to reach out to their potential patients. Social media would also enable them to educate and even tell the layman about the latest upgrades within health that are taking place while also establishing credibility.

Shaping the future of careers in Technology in healthcare

The fact is that digitalization within healthcare goes on to bring opportunities for careers to those professionals who are investing in digital skills, and hence patients are anticipated to benefit from such advanced care. If one has to have success in model healthcare, adoption of the best technologies is a necessity.

According to the researchers involved, the use of telemedicine apps in the surveillance and treatment of high-risk pregnancies has risen dramatically in prenatal health services as a result of the COVID-19 pandemic. A strong evidence-based assessment of the usefulness of telehealth arose as a result of all this, the researchers added and that and this constituted the framework for the development of the latest research.

WHY DOES IT MATTER?

According to the researchers, roughly 22% of pregnancies are classified as high-risk due to long-term health concerns, infections, past pregnancy difficulties, and perhaps other factors. The researchers are of the opinion that the care of an elevated pregnancy may require a tailored and inventive strategy, and one of these cutting-edge methods is telehealth, which has grown significantly in recent years.

Over the last five years, the research team looked at papers involving telemedicine and high-risk pregnancies from throughout the world. Mobile apps, a web-based platform, and phone conversations were among the interventions. They discovered that telehealth treatments improved maternal and neonatal health and reduced costs. The findings are important because they show that current technologies may be utilised to control high-risk pregnancies.

The telehealth strategy reduced the overall number of face-to-face and ultrasonography visits while raising the quantity of phone nursing follow-ups and overall nurse interventions. Non-stress appointments and those seeking emergency obstetric care were not affected.

Through use of antenatal corticosteroids as well as hypoglycemic medication at delivery, conformance with actual blood glucose measurements, and induction intervention at delivery were all less in the telehealth cohort, but the use of antenatal corticosteroids and hypoglycemic medication at delivery, compliance with actual blood glucose measurement techniques, and induction intervention during delivery were all significantly higher. The rates of maternal mortality were also higher. Since this conclusion is based on the findings of just one study in the analysis, the study team concluded, it is evident that far more research is essential. The same may be said about neonatal mortality.

Medical therapy, total gestational weight gain, pregnancy-related health problems, method and side effects of delivery, maternal intensive care admittance, fetal-neonatal development and growth, neonatal health issues and death, follow-ups, and care costs were all similar between the groups. The researchers noted that the results studied included multiple pregnancy risk classes, were collected from several telemedicine apps, and were handled from a broad view that covered mother, foetal, and financial effects, all contributing to its strengths and reinforcing the outcomes.

THE GROWING TREND

To solve the maternal health and mortality crisis in the United States, researchers and innovators have resorted to technology, such as remote health monitoring and other telemedicine services. Other experts have suggested that connectivity is a critical component of meeting maternity care needs.

In a December interview, Mayealie Adams, managing director of government and external affairs at Philips, said that with more data on the crossover between pregnancy outcomes and elevated internet access, they can effectively assign their broadband resources in such a manner that most efficaciously rewards communities that need them, especially in the area of maternal health.

IN THE BOOKS

The study authors said that the findings of this study, as well as international health organisation suggestions, demonstrate that healthcare practitioners and admins can use telecare as a secure method in the tracking and care of pregnancies at high risk, leading to the success of antepartum care services.

At the same time, it may be advised that randomised controlled trials on the impact of telehealth on various risk groups during pregnancy be done. This would lead to significant studies and meta-analysis that would provide greater evidence.